Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310388
Status:
TERMINATED
Last Update Posted:
2018-11-15
First Post:
2006-03-30
Brief Title:
Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial 115097
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline